SILVERBERG: As a board-certified dermatologist in an academic referral center, I encounter a substantial caseload of patients with atopic dermatitis and other chronic inflammatory skin conditions.
Experts discuss the foundational role of topical therapies in pediatric atopic dermatitis management, highlighting the importance of individualized regimens that balance efficacy and safety, ...
Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to ...
- VTAMA® (tapinarof) cream, 1% demonstrated early, significant, and meaningful achievement of both no-to-minimal itch (mean weekly PP-NRS≤1) and sleep improvement in ADORING 1 and ADORING 2. - 31.4% ...
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...
Interleukins are a driver of atopic dermatitis, fueling inflammation and itch. Managing itch requires a mix of moisturizers, lifestyle changes and target therapies such as IL inhibitors. In this ...
Derm-Biome Pharmaceuticals, Inc., a Vancouver-based biopharmaceutical company focused on skin health and longevity, today announced positive preclinical results for its novel small molecule, DB-006.
Atopic dermatitis (AD) is mainly characterized by cycles of skin rashes, intense itching, dryness, and skin sensitivity. But this chronic and relapsing condition can come with hidden challenges as ...
Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and irritated, and the itching can be so severe that it interferes with sleep and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results